Market research
NRO.PA Neurones S.A
PA EUR Technology
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 881M
- P/E ratio
- 16.21
- Analyst target
- 45
- Dividend yield
- 3.8%
- Beta
- 0.46
Profile
Instrument facts
- Exchange
- PA
- Currency
- EUR
- Sector
- Technology
- Industry
- Information Technology Services
- ISIN
- FR0004050250
- Market cap
- 881M
- P/E ratio
- 16.21
- Analyst target
- 45
- Dividend yield
- 3.8%
- Beta
- 0.46
About
About Neurones S.A
Neurones S.A. provides infrastructure, application, and consulting services in France and internationally. The company offers infrastructure automation, DevOps, cybersecurity, user support, digital workspace, and IT service management, as well as public, private, and hybrid clouds. It also provides digital, UX/UI, mobility,data, and artificial intelligence; SAP integration deployment of new modules and applications; BPM, RPA, dematerialization, and archiving; IT training; and market finance. In addition, the company offers strategy consulting, management and digital transformation consulting, digital marketing consulting, and HR transformation consulting services. It serves banking/insurance, services/consumer goods, energy/utilities/healthcare, technology/media/telecoms, industry/construction and civil engineering, and public sector markets. Neurones S.A. was founded in 1984 and is headquartered in Nanterre, France.
Research context
Neurones S.A appears in PyInvesting’s Paris Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Technology
- Industry
- Information Technology Services
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the NRO.PA discussion.
5 years, 6 months ago
Neurones S.A is currently in a long term uptrend where the price is trading 14.0% above its 200 day moving average.
From a valuation standpoint, the stock is 59.7% cheaper than other stocks from the Technology sector with a price to sales ratio of 1.4.
Neurones S.A's total revenue rose by 98.6% to $254M since the same quarter in the previous year.
Its net income has increased by 81.1% to $14M since the same quarter in the previous year.
Finally, its free cash flow fell by 65.8% to $8M since the same quarter in the previous year.
Based on the above factors, Neurones S.A gets an overall score of 4/5.